chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Flushing of face and chest; Severe pain and muscle spasticity in feet, legs, back; Left arm sore/ Severe pain and muscle spasticity in feet, legs, back; Severe pain and muscle spasticity in feet, legs, back; have difficulty walking; moderate muscle cramp; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 53-years-old non pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection; batch or lot number: fa6780) via an unspecified route of administration, administered in left arm on 01Aug2021 12:00 PM (at the age of 53 years old) as dose 1, single dose for covid-19 immunization. Patient was non pregnant at the time of vaccination. The patient's medical history included known allergies to cipro, latex, zucchini from unspecified date to unspecified date unknown date. No covid prior to vaccination. The patient's concomitant medications included sulfamethoxazole, trimethoprim (BACTRIM DS) taken for an unspecified indication, start and stop date were not reported. The patient previously took cipro [ciprofloxacin] and experienced drug hypersensitivity. No other vaccine received in four weeks. On 01Aug2021 13:30, the patient experienced flushing of face and chest, severe pain and muscle spasticity in feet, legs, back, left arm sore, moderate muscle cramp and have difficulty walking. Not tested for covid post vaccination. Therapeutic measures were taken as a result of all the events and treatment included Baclofen, Meloxicam. The outcome of the events not recovered or not resolved.  Follow-up attempts are completed. No further information is expected.
I had the J&J shot in April of 2021 and I decided to get Pfizer for my booster.   Chills, Fever,  Nausa , Fatigue and dizziness.  I also had Covid in Feb of 2021.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 26Nov2022 at 18:00 as dose number unknown, single (Batch/Lot number: unknown) at the age of 44 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: COVID 19 Treatment. Therapeutic measures were taken as a result of drug ineffective, covid-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Third episode of diarrhea on 21 March 2021; Second episode of diarrhea on 17 March 2021; First episode of diarrhea on 14 March 2021; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (First episode of diarrhea on 14 March 2021), DIARRHOEA (Second episode of diarrhea on 17 March 2021) and DIARRHOEA (Third episode of diarrhea on 21 March 2021) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 029A21A) for COVID-19 vaccination.     The patient's past medical history included Osteosarcoma (cancer in right arm).   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Mar-2021, the patient experienced DIARRHOEA (First episode of diarrhea on 14 March 2021). On 17-Mar-2021, the patient experienced DIARRHOEA (Second episode of diarrhea on 17 March 2021). On 21-Mar-2021, the patient experienced DIARRHOEA (Third episode of diarrhea on 21 March 2021). At the time of the report, DIARRHOEA (First episode of diarrhea on 14 March 2021), DIARRHOEA (Second episode of diarrhea on 17 March 2021) and DIARRHOEA (Third episode of diarrhea on 21 March 2021) outcome was unknown.            Treatment drugs were not provided concomitant drugs were not provided   Patient stated that the pharmacist told her that diarrhea can last for a week.
Information has been received from a health professional concerning a 6 year old female who on 27Jul1998 was vaccinated SC in the right arm with a first dose of varicella virus vaccine live. Concomitant vaccination the same day included a first dose of measles virus vaccine live (Moraten) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) given in the left arm. On 02Mar2004 the pt developed chickenpox lesions greater than 57 with 17 scabbed over. Only a slight fever was noted at onset. The end of the virus was 11Mar2004 and the pt recovered. No further information is available.
Patient received the Tdap vaccine on October 2, 2007.  On October 3, 2007, patient developed red spots on her fingers and thumbs.  Patient then lost sensation in these digits for approximately 5 days.  Patient regained sensation but fingers began peeling and this continued until October 17, 2007.  Unknown if skin sloughing has resolved.
Left side of left breast became red; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Left side of left breast became red) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (Left side of left breast became red). The patient was treated with CEFALEXIN (KEFLEX [CEFALEXIN]) at an unspecified dose and frequency. At the time of the report, ERYTHEMA (Left side of left breast became red) had resolved.            Concomitant products were not provided.  It was reported that 2 days after the first booster dose on her left arm patient experienced redness on her left breast, it was not warm or itchy. Patient went to a doctor. The redness went away after few days with medication. It was reported that patient got full "hundred ccs" dose with her booster dose.   This case was linked to MOD-2022-538686, MOD-2022-538684, MOD-2022-538687 (Patient Link).
Body ache; Bad dizziness; Headache; Sore arm ( where shot was administered); Vertigo; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN (Body ache), VERTIGO (Vertigo), DIZZINESS (Bad dizziness), HEADACHE (Headache) and VACCINATION SITE PAIN (Sore arm ( where shot was administered)) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017B21A and 004C21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (allergic to dilaudid.). Concomitant products included COLECALCIFEROL (D3) from 2010 to an unknown date, ACETYLSALICYLIC ACID (BABY ASPIRIN) from 2010 to an unknown date, BIOTIN, GLUCOSAMINE & CHONDORITIN from 2010 to an unknown date and UBIDECARENONE (COQ 10) for an unknown indication.   On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Apr-2021, the patient experienced VERTIGO (Vertigo). On an unknown date, the patient experienced PAIN (Body ache), DIZZINESS (Bad dizziness), HEADACHE (Headache) and VACCINATION SITE PAIN (Sore arm ( where shot was administered)). The patient was treated with Physical therapy (Excercise for vertigo) for Vertigo. On 14-Apr-2021, VERTIGO (Vertigo) had resolved. At the time of the report, PAIN (Body ache), DIZZINESS (Bad dizziness), HEADACHE (Headache) and VACCINATION SITE PAIN (Sore arm ( where shot was administered)) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-May-2021, SARS-CoV-2 test: positive (Positive) positive.         Most recent FOLLOW-UP information incorporated above includes: On 14-May-2021: Significant follow-up : Added concomitant products, vaccine details and events bad dizziness and sore arm ( where shot was administered) having outcomes unknown. Updated stop date and outcome to resolved of event vertigo. Added treatment provided. On 16-Jul-2021: NNI received
3" x 3" redness & swelling 2 days after vaccine. Redness down/improved within next 48 hrs. Lt leg.
Hurts to raise arm, hurts to use arm, limited range of motion, hurts to rotate arm, there is stiffness when using the arm.
I noticed a few days after receiving the Moderna vaccine that I was feeling a tightness in my throat but it wasn?t preventing me from daily activities and was not impacting my breathing but was still bothersome. I wanted to share this information in case  someone needed to know. I figured out that this occurred after I took the Metoprolol and Flecainide when I woke up and before I had anything to eat or drink (besides a sip of water).
On Sunday, Jan 31, 2021 I woke up around noon after working a graveyard shift and wasn't feeling right.  There was a pressure in my head, along with sinus and ear pain and a fuzzy feeling in my face.  By Monday, Feb, 1, 2021, the pain was worse now with a fatigued feeling after sleeping 20 of the last 24 hours.  I went to my Dr on 2/1/2021 and recognized a slide on the left side of my face.  From my forehead not wrinkling up the same as right side, left eye wasn't closing as tight and the left cheek and side of mouth were sliding.  He said it was Bells Palsy.  He prescribed 10 days of prednisone  and an antivirus medicine to be taken 3 times a day. That week I slept a lot and wasn't able to sit up much due to the head pain and the lightening bolt feeling in my face.    By the 2nd week I was able to sit up more, but still very tired/fatigued.   I was off work for 2 weeks, returning to work on 2/14/2021. There is still a slight slide on the left side in the eye and cheek.
The client was accompanied by his mother. Staff vaccinated the client. When filling out the consent form, the client started looking pale and was about to pass out. Staff caught the client before falling off the chair. They laid him down and put a cool pack on his neck. Called 911 to scene at 1731. EMT arrived at the scene at 1740. The client passed out for a minute but was still breathing. Vitals BP, 124/66, HR 56, Pulse Ox, 98%.  Vaccinated lot num Pfizer EW0179 exp. 08/2021. EMT Transported client at 06:05pm
Inoculation 2 of SHINGRIX Vial Kit administered in the morning of 9/08/18. I did not have a reaction to the first shot in the series, just a sore arm. Ten hours later I began with uncontrollable shivering, no fever. This was followed by a bad headache, vomiting and diaherea. These symptoms continued until 6 am the next morning. I did not contact my physician because the symptoms subsided.
6/23/09.  Itch developed and got worse not resolved with BENADRY tabs/cream.  Unable to go to MD.  7/1/09 Dr. - evaluated.  7/1/09 - Itching and hives up to shoulders (no facial, head or neck) started on PREDONISONE tapering dose and antihistamines & Hives were visible.  7/6/09 - PREDNISONE course completed.  Itching Med:  7/12/09 - Was restarted on PREDNISONE taping dose.  7/13/09 Dr.  - Dermatologist.  recommended to cancel all HEP B vaccine and informed her that reaction may be related to HEP B vaccine.
This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 23-FEB-2017, the patient was vaccinated with improprerly stored dose of M-M-R II lot # M002418 with an expiration date 12-JAN-2018 for prophylaxis (dose, route of administration and anatomical location were not reported). There was no adverse effect reported. Administered dose of M-M-R II experienced the temperature excursion of -14.4 degrees Celsius for 54 minutes. There was no previous temperature excursion reported. A digital data logger was involved. This is one of several reports received from the same reporter. Additional information is not expected, all information has already been obtained.; Sender's Comments: US-009507513-1611USA011831: US-009507513-1611USA004113: US-009507513-1705USA009742: Original Case : 1705USA009742.
No complication noted after 15 minutes wait. Patient returned about 20 minutes after vaccines stating some difficulty breathing. No rash/angioedema symptoms.
pt recvd vax;later in eve, had small, raised, red area surrounding pnu immune site;very edematous, hot to the touch & red; no fever; tx w/ analgesics;
1. Severe fatigue lasting 10+ days post vaccine,  2. Headache lasting 3 days post vaccine, 3. Soaking night sweats lasting 10 days post vaccine,  4. Hot flashes / Clammy lasting 10+ days post vaccine,  5. Rash on torso starting 2 days after vaccine and lasting 4 days after onset,  6. Malaise lasting 10 days post vaccine 7. Loss of appetite lasting 4 days post vaccine
This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 10-MAY-2018, the patient was vaccinated with a dose of expired VAQTA per intramuscular route, lot # M022531, expiration date 23-FEB-2018, (strength and frequency not reported) for prophylaxis. No adverse effect was reported.
Adverse effects on the vaccination; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (Adverse effects on the vaccination) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (Adverse effects on the vaccination). At the time of the report, ADVERSE EVENT (Adverse effects on the vaccination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications details were not reported by the reporter.
Bleeding of gums when flossing, nose bleed, small amount of blood in stools and large bruise at injection site.
This spontaneous report was received from a medical assistant referring to three patients of unknown age and gender. The patients' medical histories, concurrent conditions and drug reactions were not reported. On 07-SEP-2016, the patients were vaccinated with an improperly stored dose of PROQUAD (which had a lot # L017140 and expiration date on 13-NOV-2016) (dose number, dose and route were not reported). Concomitant medication information was not provided. No adverse event were reported and no product quality complaint (PQC) was involved. Additional information has been requested.
Presented to medical at 2109 25AUG11 with lower lipidemia and B/L eye redness/injection. No rashes, tongue edema or airway involvement. Given BENADRYL 50mg po q6h x 3 days and Ranitidine 150mg po q12h x 3 days. Complete resolution of sx in 24 hours. No family history of vaccine rxns or allergies. No prior rxn to influenza vaccine.
I experienced soreness in my left arm, headache, wheezing, coughing, fever and sore throat.
MYSTERIOUSLY DIED AFTER GETTING VACCINATED; This spontaneous report received from a consumer via a company representative concerned multiple patients (2 patients) of unknown race and ethnicity.  No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, batch number and expiry date were not reported) dose not reported, 1 total, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  It was reported that "I know 2 different people who mysteriously died after getting vaccinated. I just hope we all live". On an unspecified date, the patient mysteriously died after getting vaccinated. On an unspecified date, two patient's died from unknown cause of death. It was unknown if an autopsy was performed or not. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).; Sender's Comments: V0: 20220231988-COVID-19 VACCINE AD26.COV2.S- mysteriously died after getting vaccinated. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable.; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH
This medically confirmed spontaneous report (initial receipt 07-Dec-2011) concerns a 71-year old female patient, who had a medical history of COPD (chronic obstructive pulmonary disease) and allergy to 'Vilox'. Concomitant medication included steroids for COPD. On 21-Oct-2011 the patient received flu vaccine. On the same day she also received ZOSTAVAX 1 time subcutaneously to prevent shingles. On '17-Oct-2011' (as reported) the patient had bruising around waistline and her naval turned purple on right hand side of body. She also had lump on right hand side of body. The patient sought medical attention. The adverse event improved and she was on therapy. She was treated with hydrocodone; paracetamol combination. The event outcome was not recovered. The reporter considered events to be serious as the events caused hospitalisation / prolonged hospitalisation.
This spontaneous report as received from a health care worker refers to a patient of unknown age and gender. On an unknown date, the patient was vaccinated with GARDASIL (dose, route and lot# not provided). On an unknown date, the patient may have received a GARDASIL dose too early. No adverse effects were reported. Additional information is not expected.
I had a lot of burning in my entire upper left arm minutes after receiving the Pfizer Booster. Then I felt a lot of internal itching. Then I had a very important swelling with a localized lump in my left armpit; what appears to be a very swollen and painful lymph node.
Vaccine administered 5:45 pm, 10/15 no problems - patient left clinic feeling fine. 3 am awoke with joint pain in wrist and headache. Took MOTRIN one at 7:30 am, feeling tired and pain 6 out of 10. Injection sites no redness/swelling.
Arrived to ED complaining of increased work of breathing, black stool and chest pain. Vaccination prior day incidental to medical findings not suspected to be caused by vaccine.  64 years male with PMH of multiple upper GI bleed secondary, atrial fibrillation, CAD, HTN, HLD, COPD on 2L, morbid obesity, OSA on CPAP who presented to the ED with black stools. Has had multiple endoscopic clips and coils placed in the past. VSS; H/H 7.5/21 on admission. His troponin was elevated and peaked at 1.68. Cath in July 2019 showed 80% proximal LAD, difficult to image secondary to an obese patient, occluded nondominant RCA, moderate disease in a large OM (40% stenosis), large anterior apical wall motion. motion abnormality, EF of 45%. GI and cardiology were consulted in the ED. He was admitted for acute blood loss anemia secondary to GI bleed, likely AVM.   While inpatient, he remained afebrile and hemodynamically stable. He required 6u RBC transfusion total during his admission (transfused for <8.0 given ischemic heart disease). GI performed upper endoscopy x2 and removed large amounts of blood clots and placed 4 additional hemoclips to stop the bleeding. Cardiology was also consulted due to elevated troponin in the setting of ischemia heart disease, and inability to have stent placement/antiplatelet therapy due to GI bleeds - recommended conservative treatment, likely type II demand ischemia. He received IV octreotide 50mcg/hr for 4 days, as well as IV PPI 40mg BID.
Moderna Covid 19Vaccine EUA Chills  Body Aches Pain in under arm and chest of the arm the shot was given tiredness
Parent stated shortly after returning home the child broke out in a raised rash. On 1-5-16 the child had a generalized rash (hives ?). The parent took the child to the doctor and steroids were prescribed for an allergic reaction.
Redness and swelling of arm after injection; Redness and swelling of arm after injection; This is a spontaneous report from a non-contactable consumer. A 13-year-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 18May2021 as 1st dose, single for covid-19 immunisation. The patient medical history and concomitant medication were not reported. The patient experienced redness and swelling of arm after injection on an unspecified date. The outcome of the events were unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Fever; Chills; Mild injection site soreness; Sinus headache; This is a spontaneous report received from a contactable consumer (patient). A 27-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection and Lot Number: EL3247 via an unspecified route of administration in left arm on 17Feb2021 at 14:00 (at the age of 27-year-old) as a single dose for COVID-19 immunization. Patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection and Lot Number: Unknown) as a single dose on an unspecified date. On 18Feb2021 at 03:00, the patient experienced fever, chills, mild injection site soreness and sinus headache. The patient did not receive any treatment for the events. The outcome for the events was recovering.
Sudden pain in left ankle joint about 8 days after vaccine, unable to stand or put weight on that leg for 3 days. Then sudden pain in big toe (inflamed) on left foot still continuing now. Elevating leg gave some relief also took Tylenol.
2 1/2 cm x 4 cm erythema & induration lower (L) deltoid area, tender.
Site: Bruising at Injection Site-Medium, Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: Body Aches Generalized-Severe, Systemic: Diarrhea-Medium, Systemic: Headache-Severe, Systemic: Nausea-Medium, Systemic: Unable to Sleep-Severe